10.16.14
UPM Raflatac announces the launch of a renewed range of labelstock products for pharmaceutical applications in the Americas. The portfolio includes special constructions developed for labeling small diameter containers, migration-safe and low-temperature compliant materials, cryopreservation-compatible products and options for end-uses where luminescence is required for missing label detection.
Narrow diameter labeling with RP360 adhesive
UPM Raflatac’s products featuring RP360 adhesive meet exacting industry requirements for compliance and change control while delivering exceptional performance on small surface areas. These label stocks provide secure adhesion on small-diameter glass and plastic substrates – including test tubes as narrow as eight millimetres in diameter – with no edge lifting. When paired with a thin polypropylene (PP) face stock, RP360 products can be run as single- or dual-layer labels, and they can be used as peel-back labels when a metallized second layer is employed. RP360 is also ideal for producing multi-wrap labels on extreme-mandrel substrates, such as very small PP and HDPE test tubes.
RP31 Purus – A new standard in migration-safe adhesion
Pharmaceutical substances are typically in prolonged contact with their primary packaging, and the ongoing shift from glass to absorption-prone plastics like LDPE is requiring companies to take extra care in the selection of their label materials for both functionality and chemical safety. Because of this, UPM Raflatac has developed a range of products constructed with RP31 Purus, an innovative, high-performance adhesive that minimizes the risk of migration in medical, pharmaceutical and healthcare applications. These label stocks are pharmaceutically compliant (with documentation available upon request) and provide good mandrel performance.
RP80LT – High functionality at low temperatures
UPM Raflatac has developed a unique product range based on RP80LT, an adhesive formulated to withstand storage condition temperatures as low as -112°F (-80°C). These label stocks also bring an innovative capability to a variety of applications, as they are able to endure up to 10 freeze-thaw cycles when samples are warmed at room temperature or in warm or iced water and later returned to the freezer. RP80LT products are ideal for a variety of surface types and applications, including glass, PP and small diameter containers, and the face stocks used are variable information printable and receptive to special pens designed to mark data in low temperatures.
Cryopreservation labeling made easy with RPCryo
In cryogenic storage, sample identification is crucial. If biological samples are unidentifiable, they are virtually lost forever, which negatively impacts research and forensic investigations – and puts patient safety at risk. Luckily, UPM Raflatac’s new label stocks featuring RPCryo adhesive can withstand direct and long-term immersion in liquid nitrogen in temperatures as low as -320°F (-196°C). Additionally, RPCryo products are thermal transfer printable, which allows for automated sample management and helps eliminate the possibility of human error in terms of incorrect or illegible marking. These materials also tolerate multiple freeze-thaw cycles and adhere to cryopreservation tubes without cracking, peeling or degrading – ensuring data security throughout the cryogenic life cycle.
Luminescent label detection with RP31L
UPM Raflatac’s RP31L product range helps make patient safety a priority with missing label detection, secure adhesion and excellent clarity. Designed for detecting label presence via a luminescent detector, RP31L adhesive’s special formulation offers a safe, simple, consistent solution compared to luminescent varnishing on-press. RP31L is ideal for tight mandrel labeling and is available with a range of face stocks and liners, including clear-on-clear options ideal for examining clear liquid volumes in hospital laboratory and pharmacy environments.
“At UPM Raflatac, we work closely with companies in the pharmaceutical industry to carefully monitor trends and market needs to ensure we keep up with regulatory developments and changes,” says Daryl Northcott, Prime Business Director, Americas. “All of the products in our renewed portfolio have been designed with pharmaceutical compliance in mind, and our ultimate goal is to provide high-performance solutions that meet a variety of industry demands.”
Narrow diameter labeling with RP360 adhesive
UPM Raflatac’s products featuring RP360 adhesive meet exacting industry requirements for compliance and change control while delivering exceptional performance on small surface areas. These label stocks provide secure adhesion on small-diameter glass and plastic substrates – including test tubes as narrow as eight millimetres in diameter – with no edge lifting. When paired with a thin polypropylene (PP) face stock, RP360 products can be run as single- or dual-layer labels, and they can be used as peel-back labels when a metallized second layer is employed. RP360 is also ideal for producing multi-wrap labels on extreme-mandrel substrates, such as very small PP and HDPE test tubes.
RP31 Purus – A new standard in migration-safe adhesion
Pharmaceutical substances are typically in prolonged contact with their primary packaging, and the ongoing shift from glass to absorption-prone plastics like LDPE is requiring companies to take extra care in the selection of their label materials for both functionality and chemical safety. Because of this, UPM Raflatac has developed a range of products constructed with RP31 Purus, an innovative, high-performance adhesive that minimizes the risk of migration in medical, pharmaceutical and healthcare applications. These label stocks are pharmaceutically compliant (with documentation available upon request) and provide good mandrel performance.
RP80LT – High functionality at low temperatures
UPM Raflatac has developed a unique product range based on RP80LT, an adhesive formulated to withstand storage condition temperatures as low as -112°F (-80°C). These label stocks also bring an innovative capability to a variety of applications, as they are able to endure up to 10 freeze-thaw cycles when samples are warmed at room temperature or in warm or iced water and later returned to the freezer. RP80LT products are ideal for a variety of surface types and applications, including glass, PP and small diameter containers, and the face stocks used are variable information printable and receptive to special pens designed to mark data in low temperatures.
Cryopreservation labeling made easy with RPCryo
In cryogenic storage, sample identification is crucial. If biological samples are unidentifiable, they are virtually lost forever, which negatively impacts research and forensic investigations – and puts patient safety at risk. Luckily, UPM Raflatac’s new label stocks featuring RPCryo adhesive can withstand direct and long-term immersion in liquid nitrogen in temperatures as low as -320°F (-196°C). Additionally, RPCryo products are thermal transfer printable, which allows for automated sample management and helps eliminate the possibility of human error in terms of incorrect or illegible marking. These materials also tolerate multiple freeze-thaw cycles and adhere to cryopreservation tubes without cracking, peeling or degrading – ensuring data security throughout the cryogenic life cycle.
Luminescent label detection with RP31L
UPM Raflatac’s RP31L product range helps make patient safety a priority with missing label detection, secure adhesion and excellent clarity. Designed for detecting label presence via a luminescent detector, RP31L adhesive’s special formulation offers a safe, simple, consistent solution compared to luminescent varnishing on-press. RP31L is ideal for tight mandrel labeling and is available with a range of face stocks and liners, including clear-on-clear options ideal for examining clear liquid volumes in hospital laboratory and pharmacy environments.
“At UPM Raflatac, we work closely with companies in the pharmaceutical industry to carefully monitor trends and market needs to ensure we keep up with regulatory developments and changes,” says Daryl Northcott, Prime Business Director, Americas. “All of the products in our renewed portfolio have been designed with pharmaceutical compliance in mind, and our ultimate goal is to provide high-performance solutions that meet a variety of industry demands.”